Press Releases

10-11-2020

Nine-Month Figures Eckert & Ziegler: Growth in Radiopharmaceuticals Compensates for Corona Losses

18-09-2020, 11:30 CEST (Ad hoc press release)

Eckert & Ziegler to Run Tumor Radiation Business Through TCL Healthcare Equipment

25-08-2020

Eckert & Ziegler Receives Approval for Gallium-68 Generator for Canada

13-08-2020

Eckert & Ziegler Records Solid Half-Year Results.
Growth Trend for Radiopharmaceuticals Remains Intact.

30-07-2020

Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020

24-07-2020, 11:58 CEST (Ad hoc press release)

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

25-06-2020

Eckert & Ziegler Increases Stake in Myelo Therapeutics

12-05-2020

Q1 Performance Stable despite Oil Price Slump and Corona Expenses. Strong Growth in Radiopharmaceutical Products

11-05-2020

US health authorities to provide USD 6 million in funding for MYELO radiation protection pill

06-05-2020

Eckert & Ziegler Enters TecDAX

31-03-2020

Eckert & Ziegler with Record Profit in FY 2019

27-03-2020, 18:21 CET (Ad hoc press release)

Eckert & Ziegler: Executive Board Proposes Dividend and Share Split

26-03-2020

Eckert & Ziegler receives CE approval for innovative irradiation applicators using 3D printing

22-03-2020

Eckert & Ziegler Classified in California as Essential Business

10-03-2020

Eckert & Ziegler Starts Commercial Production of Lutetium-177

05-03-2020, 20:24 CET (Ad hoc press release)

Eckert & Ziegler Reorganizes its Production Sites

03-03-2020

Eckert & Ziegler to Financially Back Clinical Development of Innovative Lymphoma Treatment

25-02-2020

Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures

13-02-2020

Eckert & Ziegler Starts Development Cooperation for Prostate Cancer Diagnosis

05-02-2020

Eckert & Ziegler to Open up US-Production Site for Yttrium-90